PRODUCT USE ISSUE

This adverse event was reported 130931 times

These drugs are most commonly taken by patients reporting PRODUCT USE ISSUE:

# Drug Count
0 INFLIXIMAB 10430
1 DUPILUMAB 10309
2 POLYETHYLENE GLYCOL 3350 9308
3 METHOTREXATE SODIUM 7154
4 PREDNISONE 7057
5 METHOTREXATE 6312
6 DICLOFENAC SODIUM 5630
7 ACETAMINOPHEN 4746
8 NAPROXEN SODIUM 4555
9 CETIRIZINE HYDROCHLORIDE 4515
See all common drugs associated with PRODUCT USE ISSUE

PRODUCT USE ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PSEUDOEPHEDRINE HYDROCHLORIDE 1735 0.4072
1 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 93 0.3827
2 PSEUDOEPHEDRINE HCL 1768 0.3473
3 CORTISONE ACETATE 2015 0.3201
4 DESOXIMETASONE 2490 0.2644
5 CAFFEINE CITRATE 236 0.2524
6 DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM 464 0.2398
7 CETIRIZINE HYDROCHLORIDE TABLETS 2360 0.1639
8 POLYETHYLENE GLYCOL 3350 9308 0.1354
9 MOLNUPIRAVIR 146 0.1301
See all drugs enriched for association with PRODUCT USE ISSUE

PRODUCT USE ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Benzodiazepine Antagonist [EPC] 55 0.0975
1 Interleukin-4 Receptor alpha Antagonist [EPC] 10309 0.0918
2 Polyene Antimicrobial [EPC] 12 0.0663
3 Melanin Synthesis Inhibitor [EPC] 55 0.0644
4 Osmotic Laxative [EPC] 9814 0.0601
5 Interleukin-12 Antagonist [EPC] 3975 0.0589
6 Interleukin-23 Antagonist [EPC] 4209 0.0482
7 Aminosalicylate [EPC] 4444 0.0482
8 Sucrose-specific Enzyme [EPC] 3 0.0469
9 Antirheumatic Agent [EPC] 3791 0.0465
See all drug classes enriched for association with PRODUCT USE ISSUE